Trademark: 88023074
Word
RUXMEOR
Status
Dead
Status Code
606
Status Date
Monday, March 8, 2021
Serial Number
88023074
Mark Type
4000
Filing Date
Monday, July 2, 2018
Published for Opposition
Tuesday, December 11, 2018
Abandoned Date
Monday, March 8, 2021

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Mar 8, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 8, 2021
Abandonment - No Use Statement Filed
Jul 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2020
Extension 3 Granted
Jul 24, 2020
Extension 3 Filed
Jul 24, 2020
Teas Extension Received
Jan 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2020
Extension 2 Granted
Jan 10, 2020
Extension 2 Filed
Jan 10, 2020
Teas Extension Received
Aug 1, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 30, 2019
Extension 1 Granted
Jul 30, 2019
Extension 1 Filed
Jul 30, 2019
Teas Extension Received
Feb 5, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 11, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 11, 2018
Published For Opposition
Nov 21, 2018
Notification Of Notice Of Publication E-Mailed
Oct 26, 2018
Approved For Pub - Principal Register
Oct 23, 2018
Assigned To Examiner
Jul 7, 2018
New Application Office Supplied Data Entered In Tram
Jul 5, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24